Comparison of "herbal highs" composition

Analytical and Bioanalytical Chemistry

Volumn 400, Issue 1, 2011, Pages 119-126

  Zuba, Dariusz ^a   Byrska, Bogumila ^a   MacIow, Martyna ^b  

^a Institute of Forensic Toxicology   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

"Legal highs"; Cannabinoids; Chemometrics; GC MS

Indexed keywords

'LEGAL HIGHS'; ACTIVE COMPOUNDS; ACTIVE INGREDIENTS; CANNABINOID RECEPTORS; CANNABINOIDS; CHEMICAL COMPOSITIONS; CHEMOMETRICS; GC-MS; HERBAL MIXTURES; HUMAN HEALTH;

AMIDES; CHEMICAL ANALYSIS; CLUSTER ANALYSIS; ETHANOL; FATTY ACIDS; GAS CHROMATOGRAPHY; HEALTH RISKS; MASS SPECTROMETRY;

PRINCIPAL COMPONENT ANALYSIS;

CANNABINOID;

ARTICLE; COMPARATIVE STUDY; HERBAL MEDICINE; MASS FRAGMENTOGRAPHY; PRINCIPAL COMPONENT ANALYSIS;

CANNABINOIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HERBAL MEDICINE; PRINCIPAL COMPONENT ANALYSIS;

EID: 79954444738     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-4743-7     Document Type: Article

References (14)

1. A report from an EMCDDA expert meeting, Lisbon (Portugal) (2009) EMCDDA Action on new drugs briefing paper: Understanding the "Spice" phenomenon. www.tubim.gov.tr/Dosyalar/Spice.pdf, accessed on 15 March 2010
2. B Szukalski D Błachut 2010 Zmodyfikowane kannabinoidy-nowe groźne narkotyki [in Polish] Probl Krym 268 14 25
3. V Auwarter S Dresen W Weinman M Müller M Puetz 2009 Spice and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44 832 837 10.1002/jms.1558
4. N Uchiyama R Kikura-Hanajiri N Kawahara Y Goda 2009 Identification ofa cannabimimetic indole as a designer drug in a herbal product Forensic Toxicol 27 61 66 10.1007/s11419-009-0069-y 1:CAS:528:DC%2BD1MXos1Cgsrs%3D
5. N Uchiyama R Kikura-Hanajiri N Kawahara Y Haishima Y Goda 2009 Identification of a cannabinoid analog as a new type of designer drug in a herbal product Chem Pharm Bull 57 439 441 10.1248/cpb.57.439 1:CAS:528:DC%2BD1MXmtl2qu74%3D
6. MM Aung G Griffin JW Huffman W Ming-Jung C Keel B Yang VM Showalter ME Abood BR Martin 2000 Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding Drug Alcohol Depend 60 133 140 10.1016/S0376-8716(99)00152-0 1:CAS:528:DC%2BD3cXlsFCis7o%3D (Pubitemid 30625016)
7. JH Huffman R Mabon MJ Mu J Lu R Hart DP Hurst PH Reggio JL Wiley BR Martin 2003 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor Bioorg Med Chem 11 539 549 10.1016/S0968-0896(02)00451-0 1:CAS:528: DC%2BD3sXlt1Oksg%3D%3D (Pubitemid 36132231)
8. JH Huffman ALS Thompson JL Wiley BR Martin 2008 Synthesis and pharmacology of 1-deoxy analogs of CP-47, 497 and CP-55, 949 Bioorg Med Chem 16 322 335 10.1016/j.bmc.2007.09.033 1:CAS:528:DC%2BD1cXlvFSlsQ%3D%3D
9. D Lambert V Di Marzo 1999 The palmitoylethanolamide and oleamide enigmas: are these two fatty acids amides cannabimimetic? Curr Med Chem 6 757 773 1:CAS:528:DyaK1MXltlKku7w%3D (Pubitemid 29399503)
10. JD Leggett S Aspley SRG Beckett AM D'Antona DA Kendall 2004 Oleamide isa selective endogenous agonist of rat and human CB1 cannabinoid receptors Br J Pharmacol 141 253 262 10.1038/sj.bjp.0705607 1:CAS:528:DC%2BD2cXhsFOis7Y%3D (Pubitemid 38250895)
11. R Lindigkeit A Boehme I Eiserloh M Luebbecke M Wiggermann L Ernst T Beuerle 2009 Spice: a never ending story? Forensic Sci Int 191 58 63 10.1016/j.forsciint.2009.06.008 1:CAS:528:DC%2BD1MXhtFSnsLvJ
12. N Uchiyama R Kikura-Hanajiri J Ogata Y Goda 2010 Chemical analysis of synthetic cannabinoids as designer drugs in herbal products Forensic Sci Int 198 31 38 10.1016/j.forsciint.2010.01.004 1:CAS:528:DC%2BC3cXltF2nu7c%3D
13. Otto M (2007) Chemometrics. Statistics and Computer Application in Analytical Chemistry, Wiley, Weinheim
14. S Dresen N Ferreiros M Putz F Westphal R Zimmermann V Aufwarter 2010 J Mass Spectrom 45 1186 1194 10.1002/jms.1811 1:CAS:528:DC%2BC3cXhsVSku7fK